.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

OncClub: Join the Chat on Trending Trials in Cancer
Final results from the Phase 3 ClarIDHy trial
Lively expert panel discussions featuring peer-to-peer exchanges
Long-term efficacy and safety of TRK fusion-positive lung cancer treatment

SpecialtySee All >

Biosimilars
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Head & Neck Cancers
Hematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Multiple Myeloma

Advertise
About OncLive
Editorial Board
CureToday.com
TargetedOnc.com
CancerNetwork.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

Liquid Biopsy Use in Metastatic Non-Small Cell Lung Cancer

EP. 1: Genetic Testing for NSCLC

August 29th 2017

EP. 2: Widespread Mutation Testing for NSCLC

August 29th 2017

EP. 3: The Role for Liquid Biopsy in NSCLC

August 29th 2017

EP. 4: How Does Liquid Biopsy Work?

August 29th 2017

EP. 5: Clinical Applications for NSCLC Liquid Biopsy

August 29th 2017

EP. 6: Plasma Testing for NSCLC EGFR & ALK Mutations

August 29th 2017

EP. 7: Plasma Genotyping Platforms: Strengths and Limitations

August 29th 2017

EP. 8: Liquid Biopsy: Differences Among Technologies

August 29th 2017

EP. 9: Interpretation of NSCLC Plasma Genotyping Results

August 29th 2017

EP. 10: Liquid Biopsy and Next-Generation Sequencing

August 29th 2017